Study on the Efficacy and Safety of Ambroxol Combined with Methylprednisolone in Patients with Acute Lung Injury

Background There is no better treatment method towards paraquat-induced acute lung injury (ALI) at present. Ambroxol combined with methylprednisolone exhibits a significant improvement effect on ALI treatment, whereas their mechanism in ALI is still unclear.Methods 64 patients with ALI caused by paraquat poisoning brought to our hospital from January 2015 to January 2018 were selected. They were separated into a combined treatment group (CTG) and a routine treatment group (RTG) on the basis of different treatment methods. The survival of patients was observed after 7 days of treatment. Arterial blood gas, oxygen partial pressure (PaO 2 ), partial pressure of carbon dioxide (PaCO 2 ), oxygenation index (PaO 2 /FiO 2 ), patient's spontaneous respiratory rate (RR), tidal volume (VT), and positive end-expiratory pressure (PEEP) were observed before and after treatment for 7 days. Interleukin 6 (IL-6) and tumor necrosis factor α (TNF- α ) were analyzed. The differences of indexes between the dead patients and the survivors were observed, and the potential predictive value of death was analyzed.Results After treatment, the indexes of patients were significantly improved in both groups compared with those before therapy. Further comparison showed that the improvement of PaO 2 , PaCO 2 , and PaO 2 /FiO 2 in CTG was obviously higher than that in RTG ( p < 0.05). The improvement of RR, PEEP, and VT in CTG was obviously higher than that in RTG ( p < 0.05). The decreased degree of IL-6 and TNF- α in CTG was higher than that in RTG ( p < 0.05). The 7-day mortality rate of 64 patients was 39.06%, and there was no obvious difference in the 7-day survival rate in both groups ( p = 0.649). IL-6 and TNF- α were expected to be potential prediction indexes of paraquat-induced ALI.Conclusion Ambroxol combined with methylprednisolone significantly improved the oxygen partial pressure and oxygenation index of patients with paraquat-induced ALI and inhibited the inflammatory response of patients.